He has had a long-standing interest in new devices and new pharmacologic agents for percutaneous coronary and cardiac intervention, as well as quality improvement in the catheterization laboratory.
Research: New devices and drugs for coronary intervention. Percutaneous treatment of Hypertrophic, Obstructive Cardiomyopathy, Quality Assurance in the cardiac catheterization laboratory
- Interventional Cardiology
- Consultative Cardiology
Dr. Breall has an interest in and an extensive history of involvement with multi-center clinical trials involving new devices and drugs to potentially help patients in the cardiac catheterization suite. He has been the principle site investigator for over 30 studies.